title: Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
abstract: BACKGROUND
  If treatment of the axilla is indicated in patients with breast cancer who have a positive sentinel node, axillary lymph node dissection is the present standard. Although axillary lymph node dissection provides excellent regional control, it is associated with harmful side-effects. We aimed to assess whether axillary radiotherapy provides comparable regional control with fewer side-effects.
  
  
  METHODS
  Patients with T1-2 primary breast cancer and no palpable lymphadenopathy were enrolled in the randomised, multicentre, open-label, phase 3 non-inferiority EORTC 10981-22023 AMAROS trial. Patients were randomly assigned (1:1) by a computer-generated allocation schedule to receive either axillary lymph node dissection or axillary radiotherapy in case of a positive sentinel node, stratified by institution. The primary endpoint was non-inferiority of 5-year axillary recurrence, considered to be not more than 4% for the axillary radiotherapy group compared with an expected 2% in the axillary lymph node dissection group. Analyses were by intention to treat and per protocol. The AMAROS trial is registered with ClinicalTrials.gov, number NCT00014612.
  
  
  RESULTS
  Between Feb 19, 2001, and April 29, 2010, 4823 patients were enrolled at 34 centres from nine European countries, of whom 4806 were eligible for randomisation. 2402 patients were randomly assigned to receive axillary lymph node dissection and 2404 to receive axillary radiotherapy. Of the 1425 patients with a positive sentinel node, 744 had been randomly assigned to axillary lymph node dissection and 681 to axillary radiotherapy; these patients constituted the intention-to-treat population. Median follow-up was 6·1 years (IQR 4·1-8·0) for the patients with positive sentinel lymph nodes. In the axillary lymph node dissection group, 220 (33%) of 672 patients who underwent axillary lymph node dissection had additional positive nodes. Axillary recurrence occurred in four of 744 patients in the axillary lymph node dissection group and seven of 681 in the axillary radiotherapy group. 5-year axillary recurrence was 0·43% (95% CI 0·00-0·92) after axillary lymph node dissection versus 1·19% (0·31-2·08) after axillary radiotherapy. The planned non-inferiority test was underpowered because of the low number of events. The one-sided 95% CI for the underpowered non-inferiority test on the hazard ratio was 0·00-5·27, with a non-inferiority margin of 2. Lymphoedema in the ipsilateral arm was noted significantly more often after axillary lymph node dissection than after axillary radiotherapy at 1 year, 3 years, and 5 years.
  
  
  CONCLUSIONS
  Axillary lymph node dissection and axillary radiotherapy after a positive sentinel node provide excellent and comparable axillary control for patients with T1-2 primary breast cancer and no palpable lymphadenopathy. Axillary radiotherapy results in significantly less morbidity.
  
  
  BACKGROUND
  EORTC Charitable Trust.
authors.affiliation: Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
authors.forename: Mila
authors.initials: M
authors.lastname: Donker
authors.affiliation: Department of Radiation Oncology, Academic Medical Centre, Amsterdam, Netherlands.
authors.forename: Geertjan
authors.initials: G
authors.lastname: van Tienhoven
authors.affiliation: Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
authors.forename: Marieke E
authors.initials: ME
authors.lastname: Straver
authors.affiliation: Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
authors.forename: Philip
authors.initials: P
authors.lastname: Meijnen
authors.affiliation: Department of Surgery, University Medical Centre, Leiden, Netherlands.
authors.forename: Cornelis J H
authors.initials: CJ
authors.lastname: van de Velde
authors.affiliation: Department of Surgery, Cardiff University, Cardiff, UK.
authors.forename: Robert E
authors.initials: RE
authors.lastname: Mansel
authors.affiliation: Breast Unit, Careggi University Hospital, Florence, Italy.
authors.forename: Luigi
authors.initials: L
authors.lastname: Cataliotti
authors.affiliation: Institute for Radiation Oncology Arnhem, Arnhem, Netherlands.
authors.forename: A Helen
authors.initials: AH
authors.lastname: Westenberg
authors.affiliation: Department of Surgery, Rijnstate Hospital, Arnhem, Netherlands.
authors.forename: Jean H G
authors.initials: JH
authors.lastname: Klinkenbijl
authors.affiliation: Breast Unit, Careggi University Hospital, Florence, Italy.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Orzalesi
authors.affiliation: Department of Surgery, Gelre Hospital, Apeldoorn, Netherlands.
authors.forename: Willem H
authors.initials: WH
authors.lastname: Bouma
authors.affiliation: Department of Surgery, Nij Smellinghe Hospital, Drachten, Netherlands.
authors.forename: Huub C J
authors.initials: HC
authors.lastname: van der Mijle
authors.affiliation: Department of Surgery, Catharina Hospital, Eindhoven, Netherlands.
authors.forename: Grard A P
authors.initials: GA
authors.lastname: Nieuwenhuijzen
authors.affiliation: Department of Surgery, Amstelland Hospital, Amstelveen, Netherlands.
authors.forename: Sanne C
authors.initials: SC
authors.lastname: Veltkamp
authors.affiliation: European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
authors.forename: Leen
authors.initials: L
authors.lastname: Slaets
authors.affiliation: European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
authors.forename: Nicole J
authors.initials: NJ
authors.lastname: Duez
authors.affiliation: Department of Surgery, Reinier de Graaf Hospital, Delft, Netherlands.
authors.forename: Peter W
authors.initials: PW
authors.lastname: de Graaf
authors.affiliation: Department of Radiation Oncology, University Medical Center, Utrecht, Netherlands.
authors.forename: Thijs
authors.initials: T
authors.lastname: van Dalen
authors.affiliation: Department of Surgery, Medical Center Haaglanden, Westeinde, Den Haag, Netherlands.
authors.forename: Andreas
authors.initials: A
authors.lastname: Marinelli
authors.affiliation: Department of Surgery, Kennemer Gasthuis, Haarlem, Netherlands.
authors.forename: Herman
authors.initials: H
authors.lastname: Rijna
authors.affiliation: Department of Surgery, Institute of Oncology, Ljubljana, Slovenia.
authors.forename: Marko
authors.initials: M
authors.lastname: Snoj
authors.affiliation: Department of Surgery, Manchester University Hospital, Manchester, UK.
authors.forename: Nigel J
authors.initials: NJ
authors.lastname: Bundred
authors.affiliation: Department of Surgery, Haga Hospital, Den Haag, Netherlands.
authors.forename: Jos W S
authors.initials: JW
authors.lastname: Merkus
authors.affiliation: Department of Radiation Oncology, Centre Oscar Lambret, Lille, France.
authors.forename: Yazid
authors.initials: Y
authors.lastname: Belkacemi
authors.affiliation: Division of Gynecology, University Hospitals of Geneva, Geneva, Switzerland.
authors.forename: Patrick
authors.initials: P
authors.lastname: Petignat
authors.affiliation: Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.
authors.forename: Dominic A X
authors.initials: DA
authors.lastname: Schinagl
authors.affiliation: European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
authors.forename: Corneel
authors.initials: C
authors.lastname: Coens
authors.affiliation: European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
authors.forename: Carlo G M
authors.initials: CG
authors.lastname: Messina
authors.affiliation: European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
authors.forename: Jan
authors.initials: J
authors.lastname: Bogaerts
authors.affiliation: Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: e.rutgers@nki.nl.
authors.forename: Emiel J T
authors.initials: EJ
authors.lastname: Rutgers
mesh_terms: D001365:Axilla / Q000601:surgery; D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D018572:Disease-Free Survival; D005060:Europe; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology* / Q000601:surgery; D008207:Lymphatic Metastasis / Q000473:pathology / Q000532:radiotherapy*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D021701:Sentinel Lymph Node Biopsy